Thursday, April 17, 2014 Last update: 5:03 PM
Fast Breaking Live News = 100's of Daily Sales Leads

Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13

Companies mentioned in this article: Gilead Sciences, Inc.

FOSTER CITY, Calif. -- (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 32nd Annual JPMorgan Healthcare Conference in San Francisco.

John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will provide an overview of the company at the conference on Monday, January 13 at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time).

To access the live webcast or a replay via the internet log on to www.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).


Copyright © Business Wire 2014
Contact:

Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Investor Relations